½ÃÀ庸°í¼­
»óǰÄÚµå
1308572

ÀÚµ¿ ºÀÇÕ µð¹ÙÀ̽º ½ÃÀå ¿¹Ãø(-2030³â) : À¯Çüº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ¼¼°è ºÐ¼®

Automated Suturing Devices Market Forecasts to 2030 - Global Analysis By Type, Application, End User and By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Stratistics Market Research Consulting | ÆäÀÌÁö Á¤º¸: ¿µ¹® 175+ Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Stratistics MRC¿¡ µû¸£¸é ¼¼°èÀÇ ÀÚµ¿ ºÀÇÕ µð¹ÙÀ̽º ½ÃÀåÀº 2023³â 34¾ï 6,000¸¸ ´Þ·¯·Î ¿¹Ãø ±â°£ Áß 8.7%ÀÇ CAGR·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 62¾ï 1,000¸¸¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÚµ¿ ºÀÇÕ µð¹ÙÀ̽º´Â ÃÖ¼ÒÇÑÀÇ Àý°³, ÀûÀº ÃâÇ÷, ÀûÀº ¹Ù´Ã ¼Õ»ó, °¨¿°¾ø´Â ºÀÇÕÀ¸·Î ÀÛµ¿Çϸç, ÀÌ´Â ¸ðµÎ ¼º°øÀûÀÎ ¼ö¼ú¿¡ ÇʼöÀûÀÎ ¿ä¼ÒÀÔ´Ï´Ù. ÀÚµ¿ ºÀÇÕ µð¹ÙÀ̽º´Â ÀϺΠ¼ö¼ú ÀýÂ÷ÀÇ º¹À⼺À» Å©°Ô ÁÙÀÔ´Ï´Ù. ÀÚµ¿ ºÀÇÕ µð¹ÙÀ̽º´Â µÎ ÁÙÀÇ ºÀÇջ縦 ¸¸µé¾î ÇǺΠÁÖÀ§¸¦ ²ç¸Å°í ¸ÅµìÀ» ¸¸µé ¼ö ÀÖ½À´Ï´Ù. »óóÀÇ À¯Çü, ÇØºÎÇÐÀû À§Ä¡, ÇǺÎÀÇ µÎ²²¿Í ±äÀå Á¤µµ¿¡ µû¶ó ´Ù¾çÇÑ ºÀÇÕ ±â¼úÀÌ Ã¤Åõ˴ϴÙ.

WHO¿¡ µû¸£¸é ¿¬°£ ºñ Ä¡¸íÀûÀÎ ºÎ»ó ¹ß»ý °Ç¼ö¸¸ ÇØµµ ¼¼°è¿¡¼­ 2,000¸¸ °ÇÀÌ ³Ñ½À´Ï´Ù. µû¶ó¼­ »óó ¹ß»ý·ü Áõ°¡´Â »óó ¼ö¼ú °Ç¼ö Áõ°¡·Î À̾îÁ® ½ÃÀå ¼ºÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÃÀå ¿ªÇÐ :

ÃËÁø¿äÀÎ

ºÎ»óÀÚ ¼ö Áõ°¡

ÀÚµ¿ ºÀÇÕ µð¹ÙÀ̽º ¼ö¿ä¸¦ Áõ°¡½ÃŰ´Â ¿µÇâ·Â ÀÖ´Â ¿äÀÎ Áß Çϳª´Â ±³Åë»ç°í Áõ°¡ÀÔ´Ï´Ù. »óó ¹ß»ý·ü Áõ°¡¿¡ µû¸¥ »óó ¼ö¼ú Áõ°¡´Â ÀÚµ¿ ºÀÇÕ µð¹ÙÀ̽º ½ÃÀå¿¡ Àå±âÀûÀ¸·Î ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. È­»óÀ¸·Î ÀÎÇÑ ºÎ»ó, ½ºÆ÷Ã÷ ºÎ»ó, ¿Ü»ó, ³«»óÀ¸·Î ÀÎÇÑ ºÎ»óÀº ´õ ¸¹Àº »ç°íÀÇ ¿¹ÀÔ´Ï´Ù. ¹Ì±¹È­»óÇùȸ¿¡ µû¸£¸é Àüü ÀÔ¿ø ȯÀÚÀÇ 44%´Â È­»óÀ¸·Î ÀÎÇÑ °ÍÀÔ´Ï´Ù. ´ëºÎºÐÀÇ ½É°¢ÇÑ ºÎ»óÀº ¿Ü°úÀû °³ÀÔÀÌ ÇÊ¿äÇϸç, ÀÌ´Â ½ÃÀå È®´ë¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù.

¾ïÁ¦¿äÀÎ

½ÅÈï ±¹°¡ÀÇ ÀÚ¿øºÎÁ·

¿¹Ãø ±â°£ Áß ½ÅÈï ±¹°¡¿¡¼­´Â Àåºñ °íÀå À§Çè Áõ°¡¿Í ÀÎÇÁ¶ó ºÎÁ·ÀÌ ½ÃÀå ¼ºÀåÀÇ Á¦¾à ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Á¦Ç° °¡¿ë¼º ºÎÁ·, ¼÷·ÃµÈ Àü¹®°¡ ºÎÁ·, ³ôÀº Àåºñ ºñ¿ëµµ ½ÃÀå È®´ë¸¦ ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ±×·¯³ª ÀÚµ¿ ºÀÇÕ µð¹ÙÀ̽º¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í Á¦Á¶¾÷üÀÇ Á¦Ç° Çõ½ÅÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÇâÈÄ ¼ö³â°£ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

±âȸ :

³ë·ÉÀα¸ Áõ°¡

½ÃÀå È®´ëÀÇ ÁÖ¿ä ¿äÀÎÀº °í·ÉÈ­ÀÔ´Ï´Ù. °æÁ¦»çȸºÎ Àα¸°ú¿¡ µû¸£¸é 60¼¼ ÀÌ»ó °í·ÉÀÚ ºñÀ²Àº 1990³â 9.2%¿¡¼­ 2013³â 11.7%·Î Áõ°¡Çß°í, 2050³â¿¡´Â 21.1%·Î ´õ ´Ã¾î³¯ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½ÉÇ÷°ü Áúȯ, Á¤Çü¿Ü°ú Áúȯ, ½Å°æÁúȯÀº ¸ðµÎ 60¼¼ ÀÌ»ó ³ëÀο¡°Ô ¸¹ÀÌ ¹ß»ýÇÕ´Ï´Ù. µû¶ó¼­ ³ëÀÎ Àα¸ Áõ°¡¿Í ¼ö¼ú ¼ö¿ä Áõ°¡·Î ÀÎÇØ ÀÚµ¿ ºÀÇÕ µð¹ÙÀ̽º¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

À§Çù

´ëüǰÀÇ °¡¿ë¼º

ÀÚµ¿ ºÀÇÕ µð¹ÙÀ̽ºÀÇ °³¹ßÀº ¼ö¼ú¿ë ½ºÅ×ÀÌÇ÷¯, ÀÇ·á¿ë Å×ÀÌÇÁ¿Í ºØ´ë, ÁöÆÛ, ¼ö¼ú¿ë ½Ç¶õÆ® µîÀÇ Ç°¸ñ¿¡ ÀÇÇØ ¹æÇعÞÀ» ¼ö ÀÖ½À´Ï´Ù. ÇǺΠ½ºÅ×ÀÌÇ÷¯´Â Àǻ簡 Àå±â°£ Áö¼ÓµÇ´Â ÇǺΠº´º¯À» ºü¸£°Ô ºÀÇÕÇϰųª ¼ÕÀÌ ´ê±â ¾î·Á¿î ºÎÀ§¸¦ ÀýÁ¦ÇÏ´Â µ¥ »ç¿ëÇÏ´Â ÅøÀÔ´Ï´Ù. ½ºÅ×ÀÌÇ÷¯ÀÇ ¹Ù´ÃÀº ü³»¿¡¼­ ºÐÇØµË´Ï´Ù. ÀÛÀº ÇǺΠ»óóÀÇ ³¡Àº Àǻ簡 ´öÆ® Å×ÀÌÇÁ¸¦ »ç¿ëÇÏ¿© Á¢ÇÕÇÒ ¼öµµ ÀÖ½À´Ï´Ù. ÇǺΠÅ×ÀÌÇÁ´Â »óó¸¦ µ¤´Â µ¥ »ç¿ëµÇ´Â ´Ù¸¥ À¯ÇüÀÇ Àç·á¿¡ ºñÇØ Àú·ÅÇÕ´Ï´Ù. µû¶ó¼­ ÀÌ·¯ÇÑ ´ëüǰÀÇ ºÎÁ·Àº ½ÃÀå È®´ë¸¦ Á¦ÇÑÇÒ ¼ö ÀÖ½À´Ï´Ù.

COVID-19ÀÇ ¿µÇâ :

COVID-19´Â ÀÇ·á ½Ã½ºÅÛ¿¡ ¸¹Àº ½É°¢ÇÑ ¹®Á¦¸¦ ÀÏÀ¸Ä×°í, COVID-19 ÆÒµ¥¹ÍÀ¸·Î ÀÎÇØ ÀÇ·áÁø ºÎÁ·À¸·Î º´¿ø ¾÷°è¿¡¼­ µðÁöÅÐ ±â¼ú Ȱ¿ëÀÌ Å©°Ô Áõ°¡Çß½À´Ï´Ù. ¶ÇÇÑ COVID-19´Â ¸¶½ºÅ©, Àå°©, º¸È£¾È°æ µî ÀÇ·á¿ëǰ¿¡ ´ëÇÑ ¼ö¿ä¸¦ Å©°Ô Áõ°¡½ÃÄ×½À´Ï´Ù. ½ÃÀå¿¡¼­ °³ÀÎ º¸È£ ÀåºñÀÇ ÃæºÐÇϰí Áö¼ÓÀûÀÎ °ø±ÞÀ» º¸ÀåÇϱâ À§ÇØ Á¦Á¶¾÷ü´Â ÀÇ·á ¿ëǰ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¸¦ Ȱ¿ëÇÒ ¼ö ÀÖ´Â ±âȸ¸¦ ¾ò¾ú½À´Ï´Ù. ±× °á°ú COVID-19 ÆÒµ¥¹ÍÀÌ ½ÃÀå¿¡ Å« ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù.

¿¹Ãø ±â°£ Áß Àç»ç¿ë °¡´ÉÇÑ ºÎ¹®ÀÌ °¡Àå Å« ºñÁßÀ» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»ó

¿¹Ãø ±â°£ Áß Àç»ç¿ë °¡´ÉÇÑ ºÎ¹®ÀÌ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Àç»ç¿ë °¡´ÉÇÑ ÀÚµ¿ ºÀÇÕ µð¹ÙÀ̽º´Â ¸ê±Õ 󸮷ΠÀÎÇØ Á¶Á÷ ¼Õ»óÀÌ Àû°í °¨¿°¿¡ Ãë¾àÇÕ´Ï´Ù. ¶ÇÇÑ Àç»ç¿ë °¡´ÉÇÑ ±â±â´Â Àú·ÅÇÏ°í ½±°Ô ±¸ÇÒ ¼ö ÀÖÀ¸¹Ç·Î ¼ÒºñÀÚ ¼±È£µµ°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ºÀÇÕÀÌ ÇÊ¿äÇÑ ºÎ»ó°ú ¿Ü»óÀÌ Áõ°¡Çϰí ÀÚµ¿ ºÀÇÕ µð¹ÙÀ̽º¿¡ ´ëÇÑ ÀÇ»çÀÇ ¼±È£µµ°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÀÌ ºÎ¹®ÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù.

¿¹Ãø ±â°£ Áß °¡Àå ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ºÎ¹®Àº º´¿ø ºÎ¹®

º´¿ø ºÎ¹®Àº ¿¹Ãø ±â°£ Áß ±Þ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. º´¿ø¿¡ ÀÔ¿øÇϴ ȯÀÚ°¡ Áõ°¡ÇÔ¿¡ µû¶ó º´¿ø ºÎ¹® ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÈÞ´ë¿ë ÀÚµ¿ ºÀÇÕ µð¹ÙÀ̽º´Â °æ¹ÌÇÑ ºÎ»óÀ» Ä¡·áÇϰí ÀÔ¿ø ±â°£À» ´ÜÃàÇϸç Àü¹ÝÀûÀΠȸº¹ ¼Óµµ¸¦ ³ôÀÌ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ º´¿øÀº ´Ù¸¥ ȯ°æ¿¡ ºñÇØ Á¢±Ù¼ºÀÌ ³ô°í ÀÌ¿ëÀÌ ¿ëÀÌÇϸç À¯¸®ÇÑ »óȯ Á¤Ã¥À¸·Î ÀÎÇØ ½ÃÀå È®´ë¿¡ ¹ÚÂ÷¸¦ °¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

°¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÏ´Â Áö¿ª

ºÏ¹Ì´Â ¼ö¼ú °Ç¼ö Áõ°¡¿Í ³ëÀÎ Àα¸ Áõ°¡·Î ÀÎÇØ ÀÚµ¿ºÀÇÕ±â±â ½ÃÀåÀ» ÃßÁ¤ ¹× ¿¹Ãø ±â°£ Áß µ¶Á¡ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¹Ì±¹¿Ü°úÇÐȸ(ACS)ÀÇ 'Geriatric Surgery Verification(GSV) ÇÁ·Î±×·¥'Àº °í·ÉÈ­µÇ´Â ¼ºÀÎ Àα¸ÀÇ È¯ÀÚ °á°ú¸¦ ü°èÀûÀ¸·Î °³¼±Çϱâ À§ÇØ 32°³ÀÇ »õ·Î¿î ÀÇ·á ±âÁØÀ» µµÀÔÇÑ °ÍÀ¸·Î ¾Ë·ÁÁ³½À´Ï´Ù. ¹Ì±¹ Àα¸Á¶»ç±¹Àº 2010-2050³â ³ëÀÎ Àα¸°¡ 55% Áõ°¡ÇÏ¿© Àüü Àα¸ÀÇ 21%¸¦ Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. ¶ÇÇÑ ·Îº¿À» ÀÌ¿ëÇÑ ÃÖ¼Ò Ä§½À ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô°í, ÀÌ ºÐ¾ß¿¡¼­µµ ÀÚµ¿ ºÀÇÕ ±â¼úÀÇ ¹ßÀüÀÌ ¼ö¿ä¸¦ ÃËÁøÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

CAGRÀÌ °¡Àå ³ôÀº Áö¿ª :

¾Æ½Ã¾ÆÅÂÆò¾çÀº ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ¼ÒºñÀÚ ÀÎ½Ä Áõ°¡·Î ÀÎÇØ ¿¹Ãø ±â°£ Áß ±Þ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)ÀÇ º¸°í¼­¿¡ µû¸£¸é ºÎ»ó°ú ¸¸¼ºÁúȯ(¾Ï, ´ç´¢º´, Á¤½ÅÁúȯ, ½ÉÇ÷°ü°è Áúȯ, Á¤½Å°Ç°­ ¹®Á¦ µî)ÀÌ ÀεµÀÇ ÁÖ¿ä »ç¸Á ¹× Àå¾Ö ¿øÀÎÀ¸·Î ²ÅÈü´Ï´Ù. Àα¸°¡ 14¾ï ¸í¿¡ °¡±î¿öÁü¿¡ µû¶ó ÀεµÀÇ Áúº´ ºÎ´ãÀº Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ¿Í º°°³·Î, ÀÌ Áö¿ªÀÇ ±â¾÷Àº ÀÌ Áö¿ª¿¡¼­ »õ·Î¿î ȯÀÚ Ä¡·á ¿É¼ÇÀ» ¸¸µé°í ÆÇ¸ÅÇϱâ À§ÇÑ Àü·«Àû ±¸»óÀ» ³»³õ°í ÀÖ½À´Ï´Ù. ±× °á°ú, ÀÚµ¿ ºÀÇÕ µð¹ÙÀ̽º ½ÃÀå ¼ºÀåÀÌ °¡¼ÓÈ­µÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

ÁÖ¿ä ¹ßÀü :

2022³â 5¿ù, Paragon 28, Inc.´Â ¹ß°ú ¹ß¸ñÀÇ ±Þ¼º ½Ã¼ú¿¡¼­ ¿¬ºÎÁ¶Á÷ ±äÀå ¹× Àδë Àç°Ç½Ã ¹ß»ýÇÏ´Â ¹®Á¦¸¦ ÇØ°áÇϱâ À§ÇØ Grappler Suture Anchor SystemÀ» Ãâ½ÃÇß½À´Ï´Ù.

2022³â 1¿ù, Endo Tools Therapeutics°¡ °³¹ßÇÑ ³»½Ã°æ ÀÇ·á¿ë ºÀÇÕ»ç ¿£µµ¹Ì³ª(Endomina)°¡ ¹Ì±¹ ½ÄǰÀǾ౹(FDA)À¸·ÎºÎÅÍ ¼ºÀÎÀÇ ¼ÒÈ­°ü ³»½Ã°æÀû ºÀÇÕ»ç »ðÀÔÀ» À§ÇÑ ³»½Ã°æ¿ë ºÀÇÕ»ç·Î ½ÂÀι޾ҽÀ´Ï´Ù.

º¸°í¼­ ³»¿ë

  • Áö¿ª ¹× ±¹°¡º° ½ÃÀå Á¡À¯À² Æò°¡
  • ½Å±Ô ÁøÃâ ±â¾÷¿¡ ´ëÇÑ Àü·«Àû Á¦¾È
  • 2021³â, 2022³â, 2023³â, 2026³â, 2030³â ½ÃÀå µ¥ÀÌÅÍ Ä¿¹ö
  • ½ÃÀå µ¿Çâ
  • ½ÃÀå ÃßÁ¤¿¡ ±â¹ÝÇÑ ÁÖ¿ä »ç¾÷ ºÎ¹®¿¡ ´ëÇÑ Àü·«Àû Á¦¾È
  • ÁÖ¿ä °øÅë Æ®·»µå¸¦ ¸ÅÇÎÇÑ °æÀï ±¸µµ
  • »ó¼¼ÇÑ Àü·«, À繫 ¹× ÃÖ±Ù µ¿ÇâÀ» Æ÷ÇÔÇÑ ±â¾÷ °³¿ä
  • Ãֽбâ¼ú µ¿ÇâÀ» ¸ÅÇÎÇÑ °ø±Þ¸Á Æ®·»µå

¹«·á Ä¿½ºÅ͸¶ÀÌÁ¦ÀÌ¼Ç ¼­ºñ½º :

ÀÌ º¸°í¼­¸¦ ±¸µ¶ÇÏ´Â °í°´¿¡°Ô´Â ´ÙÀ½ Áß ÇϳªÀÇ ¹«·á Ä¿½ºÅ͸¶ÀÌÁ¦ÀÌ¼Ç ¿É¼ÇÀ» Á¦°øÇÕ´Ï´Ù.

  • ±â¾÷ °³¿ä
    • Ãß°¡ ½ÃÀå ±â¾÷ÀÇ Á¾ÇÕÀûÀÎ ÇÁ·ÎÆÄÀϸµ(3»ç±îÁö)
    • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®(3»ç±îÁö)
  • Áö¿ª ¼¼ºÐÈ­
    • °í°´ÀÇ °ü½É¿¡ µû¸¥ ÁÖ¿ä ±¹°¡ÀÇ ½ÃÀå Ã߻ꡤ¿¹Ãø, CAGR(ÁÖ : ½ÇÇö °¡´É¼º üũ¿¡ µû¸§)
  • °æÀï»ç º¥Ä¡¸¶Å·
    • Á¦Ç° Æ÷Æ®Æú¸®¿À, Áö¿ªÀû ÀÔÁö, Àü·«Àû Á¦ÈÞ¿¡ ±â¹ÝÇÑ ÁÖ¿ä ±â¾÷ÀÇ º¥Ä¡¸¶Å·

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼­¹®

  • ÁÖ¿ä ¿ä¾à
  • ÀÌÇØ°ü°èÀÚ
  • Á¶»ç ¹üÀ§
  • Á¶»ç ¹æ¹ý
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • µ¥ÀÌÅÍ ºÐ¼®
    • µ¥ÀÌÅÍ °ËÁõ
    • Á¶»ç ¾îÇÁ·ÎÄ¡
  • Á¶»ç ¼Ò½º
    • 1Â÷ Á¶»ç Á¤º¸¿ø
    • 2Â÷ Á¶»ç Á¤º¸¿ø
    • ÀüÁ¦Á¶°Ç

Á¦3Àå ½ÃÀå µ¿Ç⠺м®

  • ÃËÁø¿äÀÎ
  • ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • À§Çù
  • ¿ëµµ ºÐ¼®
  • ÃÖÁ¾»ç¿ëÀÚ ºÐ¼®
  • ½ÅÈï ½ÃÀå
  • COVID-19ÀÇ ¿µÇâ

Á¦4Àå Porters Five Force ºÐ¼®

  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • ±¸¸ÅÀÚÀÇ ±³¼··Â
  • ´ëüǰÀÇ À§Çù
  • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
  • °æÀï ±â¾÷°£ °æÀï °ü°è

Á¦5Àå ¼¼°èÀÇ ÀÚµ¿ ºÀÇÕ µð¹ÙÀ̽º ½ÃÀå : À¯Çüº°

  • Àç»ç¿ë °¡´É
  • ÀÏȸ¿ë

Á¦6Àå ¼¼°èÀÇ ÀÚµ¿ ºÀÇÕ µð¹ÙÀ̽º ½ÃÀå : ¿ëµµº°

  • º¹ºÎ
  • ½ÉÀåÇ÷°ü
  • Ä¡°ú
  • ¼ÒÈ­±â
  • ºÎÀΰú
  • ¾È°ú
  • Á¤Çü¿Ü°ú
  • ¿Ü»ó
  • ±âŸ ¿ëµµ

Á¦7Àå ¼¼°èÀÇ ÀÚµ¿ ºÀÇÕ µð¹ÙÀ̽º ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • Áø·á¼Ò
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • º´¿ø
  • ±âŸ ÃÖÁ¾»ç¿ëÀÚ

Á¦8Àå ¼¼°èÀÇ ÀÚµ¿ ºÀÇÕ µð¹ÙÀ̽º ½ÃÀå : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ´ºÁú·£µå
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ³²¹Ì
    • ¾Æ¸£ÇîÆ¼³ª
    • ºê¶óÁú
    • Ä¥·¹
    • ±âŸ ³²¹Ì
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • īŸ¸£
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå ÁÖ¿ä ¹ßÀü

  • °è¾à, ÆÄÆ®³Ê½Ê, Á¦ÈÞ, ÇÕº´»ç¾÷
  • ÀμöÇÕº´
  • ½ÅÁ¦Ç° Ãâ½Ã
  • »ç¾÷ È®´ë
  • ±âŸ ÁÖ¿ä Àü·«

Á¦10Àå ±â¾÷ °³¿ä

  • Apollo Endosurgery, Inc
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Becton, Dickinson & Company
  • Boston Scientific Corporation
  • C. R. Bard, Inc
  • EndoEvolution, LLC
  • Ethicon, Inc.(Johnson & Johnson)
  • LSI Solutions, Inc.
  • Medical Devices Business Services, Inc
  • Medtronic
  • Smith & Nephew, Inc.
  • SuturTek Inc.
KSA 23.08.07

According to Stratistics MRC, the Global Automated Suturing Devices Market is accounted for $3.46 billion in 2023 and is expected to reach $6.21 billion by 2030 growing at a CAGR of 8.7% during the forecast period. Automated suturing devices work with minimal incisions, little blood loss, fewer needle injuries, and infection-free suturing, all of which are crucial to the success of surgical procedures. Automated suturing devices significantly reduce the complexity of some surgical procedures. The automated suturing apparatuses can create a double row of sutures, sew them around the skin, and knot them. Depending on the type of wound, its anatomic location, and the thickness and degree of skin tension, various suturing techniques are employed.

According to the WHO, the annual number of non-fatal injuries alone contributes to more than 20 million cases worldwide. Hence, an increase in the incidence of wound injury is leading to a rise in the number of wound surgeries, which is expected to positively impact the growth of the market.

Market Dynamics:

Driver:

Increase in the number of injuries

One of the high-impact factors driving up demand for automated suturing devices is an increase in the number of traffic accidents. Increased wound surgeries as a result of an increase in wound injury incidence are anticipated to have a long-term positive effect on the market for automated suturing devices. Burn-related injuries, sports-related injuries, trauma, and fall injuries are examples of additional accidents. According to the American Burn Association, 44% of all hospital admissions were due to burn injuries. The majority of severe injuries require surgical intervention, which significantly contributes to the market's expansion.

Restraint:

Lack of resources in emerging economies

During the forecast period, market growth is anticipated to be constrained by the growing risk of device failure and the lack of infrastructure in developing nations. Poor product availability, a lack of skilled professionals, and high device costs are additional factors preventing the market from expanding. However, the increasing demand for automated suturing devices and rising product innovations from manufacturers are anticipated to offset impediments and propel market growth in the coming years.

Opportunity:

Growing geriatric population

The primary factor driving market expansion is the aging population. The population division of the Department of Economic and Social Affairs estimates that the proportion of people 60 and older has increased from 9.2% in 1990 to 11.7% in 2013 and is projected to rise even further to 21.1% by 2050. Cardiovascular, orthopedic, and neurological diseases are all very common in people 60 and older. Therefore, it is anticipated that a rise in the elderly population and the demand for surgery will increase the demand for automated suturing devices.

Threat:

Availability of substitutes

The development of automated suturing devices may be hampered by items like surgical staplers, medical tapes and bandages, zippers, and surgical sealants. A skin stapler is a tool that doctors use to quickly close lengthy skin lesions or remove difficult-to-reach areas. The staple seeds also disintegrate in the body. The edges of small skin wounds are also joined by doctors using duct tape. Compared to other types of material used to cover wounds, skin tapes are less expensive. Therefore, the lack of such alternatives could restrict market expansion.

COVID-19 Impact:

The COVID-19 pandemic has caused a number of significant problems for the healthcare system. Due to a shortage of medical staff during the COVID-19 pandemic, the use of digital technologies in the hospital industry significantly increased. Additionally, COVID-19 has caused a significant increase in demand for medical supplies like masks, gloves, and protective eyewear. To guarantee a sufficient and ongoing supply of personal protective equipment in the market, manufacturers have the opportunity to take advantage of the rising demand for medical supplies. As a result, the COVID-19 pandemic has had a big impact on the market.

The reusable segment is expected to be the largest during the forecast period:

Over the forecast period, the reusable segment is expected to witness the largest market share. Through sterilization processes, the reusable automated suturing devices cause little tissue damage and are immune to infection. Reusable equipment is also inexpensive and simple to obtain, which has increased consumer preference. Furthermore, the segment is expanding due to the rise in injuries and trauma that require sutures as well as the preference of doctors for automated suturing devices.

The hospitals segment is expected to have the highest CAGR during the forecast period:

The hospitals segment is anticipated to grow at a rapid rate during the forecasted period. The rise in patients being admitted to hospitals is boosting demand for the hospital segment. Handheld automated suturing devices are helpful for treating minor injuries, shortening hospital stays, and speeding up overall recovery. Additionally, it is anticipated that the expansion of the market will also be fueled by hospitals' accessibility, availability, and favorable reimbursement policies relative to other settings.

Region with largest share:

North America is estimated to dominate the automated suturing devices market throughout the forecast timeline due to an increase in the number of surgeries and an increase in the geriatric population. The "Geriatric Surgery Verification (GSV) Program" of the American College of Surgeons (ACS) reportedly introduced 32 new medical standards with the goal of systematically improving patient outcomes for the aging adult population. The US Census Bureau projects that between 2010 and 2050, the population's older age group will grow by 55%, making up 21% of the total. Furthermore, there is a high demand for minimally invasive surgeries assisted by robots, and there have been advancements in automated suturing technology in this area, which are likely to fuel demand.

Region with highest CAGR:

The Asia Pacific region is anticipated to grow rapidly over the forecast period due to the rising prevalence of chronic diseases and consumer awareness. The World Health Organization (WHO) reports that injuries and chronic diseases (including cancer, diabetes, cancer, mental health disorders, cardiovascular disease, and mental health issues) are India's main causes of death and disability. India's illness burden is increasing as its population approaches 1.4 billion. Aside from that, regional companies are launching strategic initiatives to create and market fresh patient treatment options in this region. As a result, the market growth of automated suturing devices is likely to accelerate.

Key players in the market

Some of the key players profiled in the Automated Suturing Devices Market include Apollo Endosurgery, Inc, B. Braun Melsungen AG, Baxter International, Inc., Becton, Dickinson & Company, Boston Scientific Corporation, C. R. Bard, Inc, EndoEvolution, LLC, Ethicon, Inc. (Johnson & Johnson), LSI Solutions, Inc., Medical Devices Business Services, Inc, Medtronic, Smith & Nephew, Inc. and SuturTek Inc.

Key Developments:

In May 2022, Paragon 28, Inc. launched Grappler Suture Anchor System designed to address the challenges that are present when performing soft tissue tensioning and ligament reconstruction in acute procedures of the foot and ankle.

In January 2022, Endomina, an endoscopic medical suture device developed by Endo Tools Therapeutics, was approved by the United States Food and Drug Administration for endoscopic placement of sutures in the gastrointestinal tract on adult population.

Types Covered:

  • Reusable
  • Disposable

Application Covered:

  • Abdominal
  • Cardiovascular
  • Dental
  • Gastrointestinal
  • Gynecological
  • Ophthalmic
  • Orthopedic
  • Trauma cases
  • Other Applications

End Users Covered:

  • Clinics
  • Ambulatory Surgery Centers
  • Hospitals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026 and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Automated Suturing Devices Market, By Type

  • 5.1 Introduction
  • 5.2 Reusable
  • 5.3 Disposable

6 Global Automated Suturing Devices Market, By Application

  • 6.1 Introduction
  • 6.2 Abdominal
  • 6.3 Cardiovascular
  • 6.4 Dental
  • 6.5 Gastrointestinal
  • 6.6 Gynecological
  • 6.7 Ophthalmic
  • 6.8 Orthopedic
  • 6.9 Trauma cases
  • 6.10 Other Applications

7 Global Automated Suturing Devices Market, By End User

  • 7.1 Introduction
  • 7.2 Clinics
  • 7.3 Ambulatory Surgery Centers
  • 7.4 Hospitals
  • 7.5 Other End Users

8 Global Automated Suturing Devices Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Apollo Endosurgery, Inc
  • 10.2 B. Braun Melsungen AG
  • 10.3 Baxter International, Inc.
  • 10.4 Becton, Dickinson & Company
  • 10.5 Boston Scientific Corporation
  • 10.6 C. R. Bard, Inc
  • 10.7 EndoEvolution, LLC
  • 10.8 Ethicon, Inc. (Johnson & Johnson)
  • 10.9 LSI Solutions, Inc.
  • 10.10 Medical Devices Business Services, Inc
  • 10.11 Medtronic
  • 10.12 Smith & Nephew, Inc.
  • 10.13 SuturTek Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦